Daiwa Securities Group’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,157
| Closed | -$38K | – | 1408 |
|
|
2025
Q4 | $38K | Sell |
2,157
-10,507
| -83% | -$198K | ﹤0.01% | 1134 |
|
|
2025
Q3 | $262K | Buy |
12,664
+10,100
| +394% | +$245K | ﹤0.01% | 960 |
|
|
2025
Q2 | $55K | Sell |
2,564
-11,695
| -82% | -$267K | ﹤0.01% | 1058 |
|
|
2025
Q1 | $275K | Buy |
14,259
+11,825
| +486% | +$237K | ﹤0.01% | 900 |
|
|
2024
Q4 | $43K | Sell |
2,434
-225
| -8% | -$4.36K | ﹤0.01% | 1068 |
|
|
2024
Q3 | $58K | Hold |
2,659
| – | – | ﹤0.01% | 1055 |
|
|
2024
Q2 | $21K | Sell |
2,659
-69
| -3% | -$373 | ﹤0.01% | 1133 |
|
|
2024
Q1 | $11K | Hold |
2,728
| – | – | ﹤0.01% | 1163 |
|
|
2023
Q4 | $7K | Hold |
2,728
| – | – | ﹤0.01% | 1188 |
|
|
2023
Q3 | $5K | Hold |
2,728
| – | – | ﹤0.01% | 1164 |
|
|
2023
Q2 | $7K | Hold |
2,728
| – | – | ﹤0.01% | 1157 |
|
|
2023
Q1 | $5K | Buy |
2,728
+1,918
| +237% | +$5.23K | ﹤0.01% | 1158 |
|
|
2022
Q4 | $3K | Buy |
810
+476
| +143% | +$866 | ﹤0.01% | 1206 |
|
|
2022
Q3 | $0 | Hold |
334
| – | – | ﹤0.01% | 1392 |
|
|
2022
Q2 | $0 | Hold |
334
| – | – | ﹤0.01% | 1421 |
|
|
2022
Q1 | $1K | Hold |
334
| – | – | ﹤0.01% | 1338 |
|
|
2021
Q4 | $1K | Hold |
334
| – | – | ﹤0.01% | 1361 |
|
|
2021
Q3 | $2K | Buy |
334
+179
| +115% | +$1.28K | ﹤0.01% | 1248 |
|
|
2021
Q2 | $1K | Hold |
155
| – | – | ﹤0.01% | 1211 |
|
|
2021
Q1 | $1K | Hold |
155
| – | – | ﹤0.01% | 1222 |
|
|
2020
Q4 | $1K | Buy |
+155
| New | +$656 | ﹤0.01% | 1202 |
|
Other funds holding SMMT
BBA
VCM
VPM
